Madison Square Garden 주식 (NYSE: MSGE)

에 대한 최신 뉴스 Madison Square Garden (NYSE:MSGE) 주식

Madison Square Garden

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Entertainment

Commodities

Sports

Exclusives

Trading Ideas

BANR

MSGE

MSGS

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga&#39;s Stock Whisper Index)&#39;는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 표면 바로 아래에서 주목을 받을 만한 주식 5종목을 소개한다.

벤징가의 &#39;스톡 위스퍼&#39; 지수: 투자자들이 몰래 주시하지만 아직 말하지 않는 주식 5종목

Madison Square Garden Entertainment Corp. Class A Common Stock

Madison Square Garden Entertainment Corp

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling by more than 300 points on Friday.
The Dow traded down 0.78% to 43,410.32 while the NASDAQ fell 2.50% to 18,630.37. The S&amp;P 500 also fell, dropping, 1.51% to 5,859.61.
Check This Out: <a href="https://www.benzinga.com/24/11/42005109/top-4-utilities-stocks-that-may-keep-you-up-at-night-this-quarter">Top 4 Utilities Stocks That May Keep You Up At Night This Quarter</a>
Leading and Lagging Sectors Utilities shares rose by 1% on Friday.
In trading on Friday, information technology shares fell by 2.7%.
Top Headline
The total number of active U.S. oil rigs fell by one to 478 rigs this week, Baker Hughes Inc reported.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>The Arena Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>) shares shot up 181% to $1.63 after it announced its first ever profitable quarter.</li>
<li>Shares of Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) got a boost, surging 55% to $20.59 after the energy company became the latest to announce a major deal to power AI data centers. Bloom Energy announced Thursday evening that it has signed a supply agreement with American Electric Power Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) for up to 1 gigawatt (GW) of its products, the largest commercial procurement of fuel cells in the world to date.&nbsp;</li>
<li>Simpple Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) shares were also up, gaining 46% to $1.29 after the company announced a $400,000 contract to supply autonomous cleaning robots at Singapore&#8217;s International Airport Terminal.</li>
</ul>
Equities Trading DOWN
<ul>
<li>TFF Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) shares dropped 77% to $0.37 after the company announced it will wind down its operations.</li>
<li>Shares of Eyenovia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) were down 70% to $0.10 after the company announced that its CHAPERONE trial is not meeting its primary endpoint, prompting the discontinuation of the study and a review of the full data set to evaluate next steps for the program.</li>
<li>Ryvyl Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) was down, falling 26% to $1.26 after the company reported worse-than-expected third-quarter financial results and cut its FY24 sales guidance.</li>
</ul>
Commodities In commodity news, oil traded down 2.2% to $67.20 while gold traded down 0.1% at $2,572.20.
Silver traded down 0.5% to $30.425 on Friday, while copper fell 0.5% to $4.0690.
Euro zone
European shares closed mostly lower today. The eurozone's STOXX 600 fell 0.77%, Germany's DAX fell 0.27% and France's CAC 40 fell 0.58%. Spain's IBEX 35 Index gained 0.97%, while London's FTSE 100 fell 0.09%.
The annual inflation rate in Italy increased to 0.9% in October versus 0.7% in the prior month, while France&#8217;s annual inflation rate rose to 1.2% in October. The GDP in the UK grew by 1% year-over-year during the third quarter.
Asia Pacific Markets
Asian markets closed lower on Friday, with Japan's Nikkei 225 gaining 0.28%, Hong Kong's Hang Seng Index falling 0.05% and China's Shanghai Composite Index dipping 1.45%.
Hong Kong's economy expanded by 1.8% year-over-year in the third quarter compared to a 3.2% increase in the previous period. China&#8217;s retail sales rose by 4.8% year-over-year in October, while industrial production rose by 5.3% year-over-year in October.
Economics
<ul>
<li>The NY Empire State Manufacturing Index surged to 31.2 in November versus -11.9 in the previous month and topping market estimates of -0.7.</li>
<li>U.S. export prices increased by 0.8% in October, while import prices rose by 0.3% month-over-month in October.</li>
<li>U.S. retail sales rose 0.4% month-over-month in October compared to a revised 0.8% increase in September, and toping market estimates of 0.3%.</li>
<li>U.S. industrial production declined by 0.3% in October compared to a revised 0.5% declined in September.</li>
<li>The total number of active U.S. oil rigs fell by one to 478 rigs this week, Baker Hughes Inc reported.</li>
<li>U.S. business inventories rose 0.1% month-over-month in September compared to a 0.3% gain in August and versus market estimates of 0.2%.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42007351/wall-streets-most-accurate-analysts-spotlight-on-3-consumer-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Consumer Stocks With Over 7% Dividend Yields</a></li>
</ul>

Earnings

News

Eurozone

Intraday Update

Markets

AREN

EYEN

RVYL

SPPL

TFFP

Crude Oil Dips Over 2%; Bloom Energy Shares Spike Higher

Needham analyst Mike Matson reiterates Haemonetics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAE#NYSE">HAE</a>) with a Buy and maintains $112 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on Haemonetics, Maintains $112 Price Target

Macro Economic Events

Economics

Federal Reserve

Fed's Goolsbee Says Neutral Is Significantly Lower Than Where Fed Policy Rate Is Now; If Productivity Growth Stays Higher Than Trend, Need To Be Careful Relying On GDP Growth Rate To Check If Economy Is Overheating

<ul>
<li>Postal Service continues to offer a great value for shipping with our reliable service to the American people. &nbsp;</li>
<li>Pricing actions part of balanced approach under "Delivering for America," the Postal Service's 10-year plan for achieving financial sustainability and service excellence.</li>
<li>Rate changes will support the $40 billion of investments in people, technology, and infrastructure and continue the modernization and improvement of the Postal Service's operations and customer experience.</li>
<li>As we previously announced, the Postal Service will not be <a href="https://www.streetinsider.com/entities/Raising+Prices">raising prices</a> in January for our Mailing Services, therefore, the price of a First-Class stamp will remain unchanged.</li>
</ul>
WASHINGTON, Nov. 15, 2024 /PRNewswire/ -- Today, the Postal Service filed notice with the Postal Regulatory Commission (PRC) for Shipping Services price changes to take effect January 19, 2025. The proposed adjustments were approved by the Governors of the USPS this week.&nbsp;
The change would raise Shipping Services prices approximately 3.2 percent for Priority Mail service and Priority Mail Express service, 3.9 percent for USPS Ground Advantage and 9.2 percent for Parcel Select.
Although Mailing Services price increases are based on the consumer price index, Shipping Services prices are primarily adjusted according to market conditions. The governors believe these new rates will keep the Postal Service competitive while providing the agency with needed revenue. As we previously announced, the Postal Service will not be raising prices in January for our Mailing Services.
As a strategic part of the <a href="https://about.usps.com/what/strategic-plans/delivering-for-america/?_gl=1&#x2A;63lmng&#x2A;_ga&#x2A;MTU2OTA3OTA5MC4xNjU2NTIwNTUx&#x2A;_ga_3NXP3C8S9V&#x2A;MTY2NDk4ODA1NS40NDIuMS4xNjY0OTg4MDkyLjAuMC4w">Delivering for America</a> 10-year plan, these proposed changes will support the Postal Service in creating a revitalized organization capable of achieving our public service mission — providing a nationwide, integrated network for the delivery of mail and packages at least six days a week — in a cost-effective and financially sustainable manner over the long term, just as the U.S. Congress has intended.&nbsp;
The PRC will review the changes before they are scheduled to take effect. The complete Postal Service price filing, with prices for all products, can be found on the PRC website under the Daily Listings section at <a href="https://prc.arkcase.com/portal/docket-search/daily-listings">prc.gov/dockets/daily</a>. The Mailing Services filing is Docket No. CP2025-1. The price tables are also available on the Postal Service's Postal Explorer website at <a href="https://pe.usps.com/PriceChange/Index">pe.usps.com/PriceChange/Index</a>.

U.S. Postal Service Recommends New Competitive Prices For 2025; Will Not Be Raising Prices In Jan For Mailing Services; Price Of First-Class Stamp To Remain Unchanged; Change Would Raise Shipping Services Prices About 3.2% For Priority Mail Service And Priority Mail Express Service; Change Would Raise Shipping Services Prices 3.9% For USPS Ground Advantage & 9.2% For Parcel Select

Needham analyst Mayank Tandon maintains Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Buy and raises the price target from $245 to $265.

GLOB

Needham Maintains Buy on Globant, Raises Price Target to $265

WIIM

HALO

Halozyme Therapeutics shares are trading lower after the company announced a proposal to combine with Evotec.

HC Wainwright &amp; Co. analyst Edward White reiterates InflaRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFRX#NASDAQ">IFRX</a>) with a Buy and maintains $8 price target.

IFRX

HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target

Bancorp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NYSE">TBBK</a>) short percent of float has fallen 3.81% since its last report. The company recently reported that it has 6.48 million shares sold short, which is 17.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.33 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Bancorp Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731698129_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bancorp has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Bancorp's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Bancorp's peer group average for short interest as a percentage of float is 4.18%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

TBBK

How Is The Market Feeling About Bancorp?

SPS Commerce's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPSC#NYSE">SPSC</a>) short percent of float has risen 3.94% since its last report. The company recently reported that it has 719 thousand shares sold short, which is 2.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.97 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>SPS Commerce Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731698124_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for SPS Commerce has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing SPS Commerce's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, SPS Commerce's peer group average for short interest as a percentage of float is 8.08%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

SPSC

Looking Into SPS Commerce's Recent Short Interest

Monday.Com's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NYSE">MNDY</a>) short percent of float has risen 4.31% since its last report. The company recently reported that it has 2.71 million shares sold short, which is 6.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.18 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Monday.Com Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731698119_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Monday.Com has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Monday.Com's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Monday.Com's peer group average for short interest as a percentage of float is 4.93%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MNDY

Looking Into Monday.Com's Recent Short Interest

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ATNM#AMEX">ATNM</a>) with a Buy and maintains $4 price target.

ATNM

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

On Friday, Gilead Sciences, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) revealed data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study evaluating the long-term <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42012386/gileads-livdelzi-seladelpar-demonstrated-a-sustained-efficacy-and-long-term-safety-profile-in-mana" rel="noreferrer noopener">efficacy and safety of Livdelzi</a>.
The study showed that 81% (30 out of 37) of participants with primary biliary cholangitis (PBC) treated with Livdelzi&nbsp;(seladelpar) achieved a composite biochemical response (CBR), demonstrating significant improvements in a key measures of PBC progression.
Additionally, 41% (15 out of 37) of participants achieved normalization of alkaline phosphatase (ALP) levels, a critical biomarker of liver function.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41819570/hiv-drugmaker-gilead-reports-strongest-quarterly-performance-of-2024-analysts-boost" rel="noreferrer noopener">HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts Boost Price Target On Raised Outlook</a>
Livdelzi continues to appear generally well tolerated, with no new safety signals or change in frequency of adverse events (AEs) with up to three years of exposure.
In August, the FDA granted accelerated approval for&nbsp;Gilead&#8217;s Livdelzi&nbsp;for primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults who have had an inadequate response to UDCA or as monotherapy in patients&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40394698/fda-approves-gileads-seladelpar-for-inflammatory-liver-disease-acquired-via-4b-cymabay-deal" rel="noreferrer noopener">unable to tolerate UDCA</a>.
In addition to the ASSURE data, Gilead showcased findings from two oral presentations highlighting additional analyses from the Phase 3 RESPONSE trial:
<ul>
<li>At Month 12, the adjusted mean change from baseline in ALP for participants with cirrhosis on Livdelzi was -121.4 U/L (a decrease of approximately 35% from baseline) versus 23.2 U/L (an increase of approximately 6.6%) on placebo.</li>
<li>-134.8 U/L (down 43.5%) for Livdelzi versus -18.0 U/L (a decrease of approximately 5.8%) for placebo in participants without cirrhosis.</li>
<li>A secondary analysis of pruritus in RESPONSE showed that among participants with a numerical rating score (NRS) of ≥4 and NRS ≥7 at baseline, Livdelzi led to near resolution (NRS of 0 or 1) of itch at Month 12 in 26.5% and 18.8% of participants, respectively, versus 0% of participants on placebo.</li>
</ul>
Price Action: GILD stock is down 3.48% at $88.90 at last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/bonds/24/11/42003337/trumps-victory-spurs-50b-corporate-bond-surge-as-tax-cut-optimism-drives-borrowing-costs-to-25-year-low" target="_blank" rel="noreferrer noopener">Trump&#8217;s Victory Spurs $50B Corporate Bond Surge As Tax Cut Optimism Drives Borrowing Costs To 25-Year Low</a></li>
</ul>

Biotech

Equities

Large Cap

Health Care

Movers

General

GILD

Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease

Wells Fargo analyst Ike Boruchow maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Overweight and raises the price target from $65 to $75.

Wells Fargo Maintains Overweight on Tapestry, Raises Price Target to $75

HC Wainwright &amp; Co. analyst Robert Burns reiterates Y-mAbs Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMAB#NASDAQ">YMAB</a>) with a Buy and maintains $22 price target.

YMAB

HC Wainwright & Co. Reiterates Buy on Y-mAbs Therapeutics, Maintains $22 Price Target

Wells Fargo analyst Derek Archila maintains Cabaletta Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>) with a Overweight and lowers the price target from $20 to $12.

CABA

Wells Fargo Maintains Overweight on Cabaletta Bio, Lowers Price Target to $12

The recent U.S. presidential election results, including a Republican sweep, have raised questions about the future of renewable energy under President-elect Donald Trump&#8217;s leadership.
Morgan Stanley&#8217;s report evaluates the economic impact on renewables under various policy scenarios and its effects on earnings.
The analyst has adjusted its view on the clean tech industry to &#8220;In-Line&#8221; from &#8220;Attractive.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41880110/solar-renewables-stocks-crash-after-trump-win-should-you-buy-now-at-cheap-valuations" rel="noreferrer noopener">Solar, Renewables Stocks Crash After Trump Win: Should You Buy Now At Cheap Valuations?</a>
While long-term demand for renewables is likely stronger than current market perceptions, near-term growth prospects have become less clear due to new uncertainties.
It&#8217;s important to remember that these new uncertainties add to the already difficult environment facing the clean energy sector, dealing with issues such as permitting and interconnection delays, funding challenges, and intense competition that have hurt profitability.
Uncertainty about the Inflation Reduction Act (IRA), tariffs, and interest rates has significantly impacted clean fuel valuations.
Morgan Stanley writes that clear guidance on the IRA is essential for clean tech valuations to rebound. However, this may take time since it will likely be linked to discussions about the Tax Cuts and Job Act&nbsp;(TCJA), which is set to expire at the end of 2025.
Morgan Stanley recommends investing in stocks with high-quality and durable growth/ margins, with a clear catalyst path and/or strong balance sheet to weather any near-term volatility in growth and/or profitability.
<ul>
<li>The analyst maintains an Overweight rating on GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), and Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>).</li>
</ul>
However, the analyst has downgraded three cleantech stocks from Equal-weight to Underweight, including:
<ul>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>): The analyst reduced the price target from $23 to $9, citing slower profitability due to decreased European demand and tough competition from cheaper Chinese manufacturers. As a result, the company is not expected to break even on <a href="https://www.benzinga.com/quote/SEDG/analyst-ratings" target="_blank" rel="noreferrer noopener">EBITDA until after 2026</a>. At last check Friday, the stock was trading 13.2% lower at $11.13.</li>
<li>Maxeon Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>): Morgan Stanley anticipates a slow recovery to profitability due to increasing competition in Europe&#8217;s utility-scale solar market, which will likely keep pushing prices down. The analyst maintains the <a href="https://www.benzinga.com/quote/MAXN/analyst-ratings" target="_blank" rel="noreferrer noopener">price target of $4</a>. Additionally, recent customer losses in the U.S. residential market could make maintaining market share and premium pricing harder. Stock is trading 10.08% lower at $10.08 at last check Friday.</li>
<li>TPI Composites, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>): The analyst notes an uncertainty about how quickly the U.S. wind market will recover, mainly due to challenges in securing financing and recent issues with design and inspections as the industry shifts to larger blade sizes. Morgan Stanley has cut the <a href="https://www.benzinga.com/quote/TPIC/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $4 to $2</a>. Stock is down 8.82% at $2.16 at the last check Friday.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42012689/life-insurance-firm-aegon-trades-higher-as-capital-ratios-remain-solid" target="_blank" rel="noreferrer noopener">Life Insurance Firm Aegon Trades Higher As Capital Ratios&#8217; Remain Solid&#8217;</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Government

Downgrades

FSLR

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

SEDG

TPIC

Trump's Win, Economic Challenges Lead to Tougher Outlook for Renewable Energy Stocks: Morgan Stanley

Wells Fargo analyst Derek Archila maintains Kyverna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYTX#NASDAQ">KYTX</a>) with a Overweight and lowers the price target from $44 to $24.

KYTX

Wells Fargo Maintains Overweight on Kyverna Therapeutics, Lowers Price Target to $24

Wells Fargo analyst Roger Read maintains Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) with a Overweight and raises the price target from $32 to $35.

CTRA

Wells Fargo Maintains Overweight on Coterra Energy, Raises Price Target to $35

Guggenheim analyst Michael Schmidt maintains Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) with a Buy and lowers the price target from $12 to $8.

ZNTL

Guggenheim Maintains Buy on Zentalis Pharma, Lowers Price Target to $8

Fed's Goolsbee Says Everything Is Always On The Fed Policy Table; Inflation Numbers Have To Keep Improving; If Started To See Reversal On Inflation Progress, Would Have To Figure Out If It Is A Bump; Not A Lot Has Changed On That In Last Couple Weeks; Recent Inflation Has Been A Little Higher Than Target, If That Is Extended, It's Too High; There's A Lot Of Volatility On Inflation Data Series

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS – Expedia (EXPE) up 4% Graham (GHM) up 16% NRG ...

Morning Movers: Expedia, Airbnb moving in opposite directions after results

Madison Square Garden Entertainment Corp. 2025 Q1 - Results - Earnings Call Presentation

Madison Square Garden Entertainment GAAP EPS of -$0.40 beats by $0.45, revenue of $138.7M misses by $0.54M

Madison Square Garden Entertainment Corp. ( ($MSGE) ) has released its Q1 earnings. Here is a breakdown of the information Madison Square Garden En...

MSG Entertainment's Q1 2025: Revenue Dips, Losses Narrow

Madison Square Garden Entertainment Corp. (MSGE) Q1 2025 Earnings Call Transcript

Analyst Cameron Mansson-Perrone of Morgan Stanley maintained a Hold rating on Madison Square Garden Entertainment Corp. (MSGE – Research Report), r...

Madison Square Garden Entertainment Corp.: Navigating Industry Challenges with a Hold Rating Amid Growth Outlook Adjustments

Seaport Global analyst David Joyce reiterated a Buy rating on Madison Square Garden Entertainment Corp. (MSGE – Research Report) today and set a pr...

Seaport Global Keeps Their Buy Rating on Madison Square Garden Entertainment Corp. (MSGE)

Macquarie analyst Paul Golding lowered the firm's price target on MSG Entertainment (MSGE) to $45 from $47 and keeps an Outperform rating on the sh...

MSG Entertainment price target lowered to $45 from $47 at Macquarie

Macquarie analyst Paul Golding has maintained their bullish stance on MSGE stock, giving a Buy rating today. Paul Golding has given his Buy rating ...

Buy Rating Maintained for MSGE Amid Mixed Revenue Outlook and Strong Long-term Demand

Guggenheim lowered the firm's price target on MSG Entertainment (MSGE) to $48 from $49 and keeps a Buy rating on the shares after having updated th...

MSG Entertainment price target lowered to $48 from $49 at Guggenheim

ABNB

BLMN

DCBO

DKNG

EXPE

LAMR

Press Releases

EARTH BRANDS NAMED AN OFFICIAL PARTNER OF MADISON SQUARE GARDEN

Madison Square Garden Entertainment Corp. to Host Fiscal 2024 Third Quarter Conference Call

MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2024 THIRD QUARTER RESULTS

Madison Square Garden Entertainment Corp. to Host Fiscal 2024 Fourth Quarter and Year-End Conference Call

MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR RESULTS

Small Cap

THE MSG FAMILY OF COMPANIES LAUNCH EXPANSIVE MULTI-YEAR PARTNERSHIP WITH GLOBAL TECHNOLOGY POWERHOUSE LENOVO AND SUBSIDIARY MOTOROLA

THE MSG FAMILY OF COMPANIES AND VERIZON EXPAND PARTNERSHIP, NAMING VERIZON THE OFFICIAL MOBILE WIRELESS PARTNER ACROSS THE COMPANIES' PORTFOLIO

'EXPERIENCE ABU DHABI' NAMED OFFICIAL NEW YORK KNICKS PATCH PARTNER

Madison Square Garden Entertainment Corp. to Host Fiscal 2025 First Quarter Conference Call

MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2025 FIRST QUARTER RESULTS

LNVGY

SPHR

AMC Entertainment Holdings, Inc. Class A Common Stock

AMC Enter Hldgs

Atlanta Braves Holdings, Inc. - Series A Common Stock

Atlanta Braves Holdings

Atlanta Braves Holdings, Inc. - Series C Common Stock

Cinemark Holdings Inc Cinemark Holdings, Inc. Common Stock

Cinemark Hldgs

Walt Disney

Endeavor Group Holdings, Inc. Class A Common Stock

Endeavor Gr Hldgs

Liberty Media Corporation - Series A Liberty Formula One Common Stock

Liberty Formula One Gr

Ordinary Shares (New Liberty Formula One) Series A

Liberty Media Corporation - Series C Liberty Formula One Common Stock

Ordinary Shares (New Liberty Formula One) Series C

iQIYI

Lions Gate Entertainment Corporation Class A Voting Shares

Lions Gate Entertainment Corporation Class B Non-Voting Shares

Lionsgate Studios

Liberty Media Corporation - Series A Liberty Live Common Stock

Liberty Live

Ordinary Shares (New Liberty Live) Series A

Liberty Media Corporation - Series C Liberty Live Common Stock

Ordinary Shares (New Liberty Live) Series C

Live Nation Entertainment, Inc. Common Stock

Live Nation Entertainment

Manchester United Ltd. Class A Ordinary Shares

Manchester United

Marcus

Madison Square Garden Sports Corp. Class A Common Stock (New)

Netflix

Roku

Sphere Entertainment Co. Class A Common Stock

Sphere Entertainment

TKO Group Holdings, Inc. Class A Common Stock

TKO Group Holdings

Tencent Music Entertainment Group American Depositary Shares, each representing two Class A Ordinary Shares

Tencent Music Enter Gr

Warner Bros. Discovery, Inc. - Series A Common Stock

Warner Bros. Discovery

Warner Music Group Corp. - Class A Common Stock

Warner Music Gr

Guggenheim

Macquarie

Morgan Stanley

B of A Securities

Goldman Sachs

매주, ‘벤징가의 스톡 위스퍼 지수(Benzinga's Stock Whisper Index)'는 독점 데이터(proprietary data)와 패턴 인식의 조합을 사용하여 <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">표면 바로 아래에서 주목</a>을 받을 만한 주식 5종목을 소개한다.
투자자들은 가치가 저평가된, 관심이 적은, 새로운 주식들을 항상 찾고 있다. 소매 거래자들이 사용할 수 있는 방법은 무수히 많기 때문에 새로운 기회를 발견하고 특정 주식이 관심을 가져야 하는 이유를 이해하기 위해 풍부한 정보를 조사하는 것이 어려운 경우가 많다.
또한 읽기: <a href="https://kr.benzinga.com/news/usa/stocks/%EB%8F%85%EC%A0%90-9%EC%9B%94-%EB%B2%A4%EC%A7%95%EA%B0%80-%ED%94%84%EB%A1%9C%EC%97%90%EC%84%9C-%EA%B0%80%EC%9E%A5-%EB%A7%8E%EC%9D%B4-%EA%B2%80%EC%83%89%EB%90%9C-%EC%83%81%EC%9C%84-20%EA%B0%9C/" target="_blank" rel="noopener">독점: 2024년 9월 Benzinga Pro에서 가장 많이 검색된 20개 종목 &#8211; 테슬라, 엔비디아, 애플, DJT 주식 순위는?</a>
<h2 class="wp-block-heading">9월 20일 주의 벤징가 스톡 위스퍼 지수의 개요:</h2>
모호크 인더스트리즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>): 이 바닥재 제품 회사는 지난주 동안 Benzinga 독자들의 큰 관심을 받았다. 해당 주식은 3분기에 S&amp;P 500에서 최고 성과를 낸 주식 중 하나였다.
모호크는 금리 인하 환경에서 수혜자로 거론되고 있으며, 2024년 대선에서 어느 후보가 승리하든 잘할 수 있다는 점에서 독자들의 주목을 받을 것으로 보인다. 바닥재 분야에서의 회사 위치 덕분에 더 많은 주택이 건설되는 것이 모호크에게는 중요한 촉매제가 될 수 있다.
모호크는 10월에 3분기 재무 결과를 발표할 것으로 예상된다. 모호크는 애널리스트들의 주당순이익(EPS) 추정치를 6분기 연속 초과 달성했으며, 매출 추정치를 6분 중 5분기에서 초과 달성했다.
아래 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1" target="_blank" rel="noopener" data-google-interstitial="false">Benzinga Pro 차트</a>에서 볼 수 있듯이 모호크 주가는 지난 5거래일 동안 2.04% 하락했으며, 2024년에는 연초 대비 46% 이상 상승했다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-581030" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197.png" sizes="(max-width: 997px) 100vw, 997px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105607/Screenshot-197-768x386.png 768w" alt="" width="997" height="501" /></a></figure>
배너 뱅크(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANR#NASDAQ">BANR</a>): 이 지역 은행은 독자들의 관심이 증가하면서 &#8216;벤징가 스톡 위스퍼&#8217; 지수에 합류했다.
주로 오리건, 워싱턴, 캘리포니아, 아이다호 그리고 유타에 지점을 두고 있는 이 은행은 10월 16일에 3분기 재무 결과를 발표할 예정이다. 이 은행은 애널리스트들의 주당순이익(EPS) 추정치를 4분기 연속 초과 달성했으며, 매출 추정치를 3분기 연속 초과 달성했다.
레이먼드 제임스(Raymond James)는 최근 주식에 대한 아웃퍼폼(Outperform) 등급을 유지하고 목표 주가를 62달러에서 65달러로 상향 조정했다. 최근 <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40926026/federal-reserve-delivers-bold-0-5-rate-cut-signals-further-easing-ahead">금리 인하</a>와 올해 말 추가 금리 인하 가능성으로 인해 은행 주식들이 투자자들의 주목을 받고 있다.
배너 뱅크의 주식은 지난주에 1.81% 올랐고, 2024년 들어 12.37% 상승했다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-581033" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198.png" sizes="(max-width: 997px) 100vw, 997px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105624/Screenshot-198-768x388.png 768w" alt="" width="997" height="504" /></a></figure>
매디슨 스퀘어 가든 엔터테인먼트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGE#NYSE">MSGE</a>): 이 상징적인 매디슨 스퀘어 가든 스포츠 및 콘서트 장소의 소유자는 주간 독자들의 관심이 증가했다.
이러한 관심 증가는 내셔널 하키 리그(NHL)와 내셔널 농구 협회(NBA) 시즌의 시작에 대한 기대감과 관련이 있을 수 있다. 매디슨 스퀘어 가든 스포츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>)는 뉴욕 레인저스(NHL)와 뉴욕 닉스(NBA)를 소유하고 있기 때문에, 이 엔터테인먼트 회사와 경기장 소유자는 높은 관람객 수와 좋은 팀 성적이 있을 때 강한 성과를 볼 수 있다.
NHL 시즌은 10월 9일 레인저스의 경기로 시작되며, 닉스는 10월 22일 첫 경기를 치를 예정이다. 닉스는 최근 NBA 슈퍼스타 칼 앤서니 타운스(Karl-Anthony Towns)를 뉴욕으로 데려오는 트레이드를 통해 이번 시즌에 대한 기대가 높다. 이번 트레이드를 통해 닉스는 이제 다음 시즌 NBA 챔피언십에서 세 번째로 높은 우승 확률(+800)을 갖게 되었다.
지난주 MSGE 주식은 0.45% 하락했다. 그러나  주식은 2024년 들어 35%  상승했다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-581035" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199.png" sizes="(max-width: 997px) 100vw, 997px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105639/Screenshot-199-768x387.png 768w" alt="" width="997" height="502" /></a></figure>
슐룸베르거 NV(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>): 이 오일 주식은 중동 긴장 고조로 인해 주가와 관심이 상승한 <a href="https://www.benzinga.com/news/24/10/41143156/oil-prices-spike-energy-stocks-jump-after-irans-missile-attack-on-israel-what-investors-need-to-know">많은 섹터 중 하나</a>이다. <a href="https://www.benzinga.com/news/global/24/10/41126038/iran-attacks-israel-with-missiles-middle-east-tensions-escalates-s-p-500-stocks-bitcoin-fall-as-oil">이란이 이스라엘에 미사일 공격을 감행</a>하면서 발생한 일이다. 공격이 증가하면 원유 공급이 차질을 빚을 수 있고 제재가 원유 가격을 상승시킬 수 있다.
슐룸베르거는 10월 18일에 3분기 재무 결과를 발표할 예정이며, 이는 주식에 대한 추가 낙관론을 불러일으킬 수 있다. 이 회사는 10분기 연속으로 애널리스트의 주당순이익(EPS) 추정치를 초과 달성한 바 있다. 또한, 3분기 연속으로 매출 추정치를 초과 달성했으며, 과거 10분기 중 8분기에서는 초과 달성했다.
슐룸베르거의 주식은 지난 5거래일 동안8% 이상 상승했다. 최근의 상승에도 불구하고 주식은 2024년 들어 12% 이상 하락했다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-581037" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200.png" sizes="(max-width: 997px) 100vw, 997px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105656/Screenshot-200-768x386.png 768w" alt="" width="997" height="501" /></a></figure>
톰킨스 파이낸셜(AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TMP#AMEX">TMP</a>): 커뮤니티 은행, 재무 상담사 및 보험 대리점 회사인 톰킨스는 잘 알려진 이름은 아니지만, 3분기 실적 발표를 앞두고 투자자들의 관심이 증가하고 있다. 다른 은행들과 마찬가지로 톰킨스는 금리 인하의 혜택을 볼 수 있다.
키프·브루옛 &amp; 우즈(Keefe, Bruyette &amp; Woods)는 최근 주식을 시장 평균에서 아웃퍼폼(Outperform)으로 상향 조정하고 목표 주가를 59달러에서 68달러로 상향 조정했다.
톰킨스 파이낸셜의 주식은 지난주에 4.42% 상승했으며, 2024년 들어 주식은 1.25% 올랐다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-581038" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201.png" sizes="(max-width: 993px) 100vw, 993px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/04105714/Screenshot-201-768x390.png 768w" alt="" width="993" height="504" /></a></figure>
다음 주 보고서를 기대해 주시고, 최신 헤드라인과 <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100424&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">주요 시장 동향 기사를 여기를 통해 확인하십시오.</a>
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40928301/interest-rates-in-free-fall-what-it-means-for-mortgages-credit-cards-and-your-wallet-a" target="_blank" rel="noreferrer noopener">금리 급락: 모기지, 신용 카드 및 지갑에 미치는 영향은? 연준이 4년 만에 처음으로 조치를 취할 때</a></li>
</ul>
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Madison Square Garden

뉴스

에 대한 최신 뉴스 Madison Square Garden (NYSE:MSGE) 주식

일요일, 10월 06, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌